Transcat, Inc. TRNS
87.73
1.60
1.86%
as of 25 Sep
- Market cap
- $806.2M
- P/E
- 237×
Follow TRNS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
59.51 | 66.74 | 126.64 | 250.73 |
P/S ratio |
2.25 | 1.66 | 2.07 | 2.49 | |
P/FCF ratio |
26.01 | 21.28 | 35.06 | 34.21 | |
P/Operating CF |
52.97 | 43.58 | 110.56 | 98.41 | |
P/B ratio |
2.31 | 1.78 | 2.28 | 2.86 | |
Price to Tangible BV |
0.00 | 0.00 | 145.00 | 0.00 | |
EV/Sales |
2.61 | 1.96 | 2.36 | 2.79 | |
EV/EBITDA |
19.73 | 15.37 | 19.77 | 24.74 | |
EV/Operating CF |
19.89 | 15.96 | 22.43 | 24.29 | |
EV/FCF |
30.12 | 25.20 | 39.98 | 38.35 | |
Quick Ratio |
1.93 | 1.73 | 1.79 | 1.93 | |
Current Ratio |
2.43 | 2.21 | 2.33 | 2.49 | |
Net Debt/EBITDA |
10.66 | 13.29 | 8.39 | 9.67 | |
Debt/Assets |
23.07% | 21.12% | 20.79% | 22.41% | |
Debt/Equity |
0.38 | 0.34 | 0.33 | 0.36 | |
Asset Turnover |
0.75 | 0.74 | 0.77 | 0.79 | |
Operating CF/Net income |
10.15 | (11.03) | 3.18 | 6.62 | |
Capex/Depreciation |
(0.68) | (0.37) | (0.51) | (0.57) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
28.27% | 30.01% | 29.26% | 29.07% | |
Intangible Assets out of Total Assets |
0.63 | 0.63 | 0.62 | 0.62 | |
Share Based Compensation of Revenue |
2.24% | 2.46% | 2.82% | 2.13% | |
Graham Net Nets |
(0.15) | (0.18) | (0.13) | (0.11) | |
Graham Number |
29.62 | 24.67 | 20.50 | 16.42 | |
Earnings Yield |
1.68% | 1.50% | 0.79% | 0.40% | |
Free Cash Flow Yield |
3.85% | 4.70% | 2.85% | 2.92% | |
Revenue per Share |
8.83 | 8.99 | 9.57 | 9.94 | |
Operating CF per Share |
1.38 | 1.30 | 0.66 | 0.94 | |
Capex per Share |
(0.48) | (0.29) | (0.38) | (0.43) | |
Free Cash Flow per Share |
0.91 | 1.01 | 0.28 | 0.52 | |
Cash per Share |
0.55 | 0.37 | 0.53 | 0.72 | |
Shareholders Equity per Share |
31.69 | 31.81 | 32.21 | 32.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.69 | 31.81 | 32.21 | 32.39 | |
Free Cash Flow |
8.45 | 9.47 | 2.61 | 4.84 | |
Working Capital |
50.44 | 44.19 | 52.83 | 57.32 | |
Capital Expenditures |
(4.43) | (2.68) | (3.59) | (3.98) | |
Net Current Asset Value |
(103.72) | (95.31) | (87.41) | (93.99) | |
EV/EBIT |
44.19 | 39.50 | 58.94 | 83.53 | |
Capex to Sales |
0.05 | 0.03 | 0.04 | 0.04 | |
Net Profit Margin |
1.54% | (1.31%) | 2.18% | 1.43% | |
Price to Operating Income |
38.15 | 33.35 | 51.69 | 74.52 | |
| Other line items | |||||
Average Receivables |
56.39 | 56.07 | 61.08 | 62.92 | |
Average Payables |
14.21 | 16.84 | 17.34 | 16.88 | |
Average Inventory |
14.31 | 13.35 | 14.09 | 15.08 | |
Average Assets |
404.22 | 429.45 | 432.86 | 442.58 | |
Average Common Equity |
282.09 | 288.93 | 293.75 | 297.72 |
Columns are period end dates